Zobrazeno 1 - 10
of 259
pro vyhledávání: '"Jose M Miro"'
Autor:
Jasmini Alagaratnam, Wolfgang Stöhr, Elizabeth Hamlyn, Kholoud Porter, Jamie Toombs, Amanda Heslegrave, Henrik Zetterberg, Magnus Gisslén, Jonathan Underwood, Mauro Schechter, Pontiano Kaleebu, Giuseppe Tambussi, Sabine Kinloch, Jose M. Miro, Anthony D. Kelleher, Abdel Babiker, John Frater, Alan Winston, Sarah Fidler
Publikováno v:
Journal of Virus Eradication, Vol 10, Iss 2, Pp 100381- (2024)
Objective: Antiretroviral therapy (ART)-conferred suppression of HIV replication limits neuronal injury and inflammation. ART interruption tests efficacy in HIV cure trials and viral rebound after ART interruption may induce neuronal injury. We inves
Externí odkaz:
https://doaj.org/article/487cf33da3b34fe190f0b5145c56c047
Autor:
Raquel Martín-Iguacel, Mari Carmen Vazquez-Friol, Joaquin Burgos, Andreu Bruguera, Juliana Reyes-Urueña, Sergio Moreno-Fornés, Jordi Aceitón, Yesika Díaz, Pere Domingo, Maria Saumoy, Hernando Knobel, David Dalmau, Beatriz Borjabad, Isik Somuncu Johansen, Jose M. Miro, Jordi Casabona, Josep M. Llibre
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
ObjectivesPeople with HIV (PWH) have a higher cardiovascular risk than the general population. It remains unclear, however, whether the risk of cardiovascular disease (CVD) is higher in late HIV presenters (LP; CD4 ≤ 350 cells/μL at HIV diagnosis)
Externí odkaz:
https://doaj.org/article/4838451d69b244e39575e4b5f38ae474
Autor:
Daniel Kwakye Nomah, Juliana Reyes-Urueña, Lucía Alonso, Yesika Díaz, Sergio Moreno-Fornés, Jordi Aceiton, Andreu Bruguera, Raquel Martín-Iguacel, Arkaitz Imaz, Maria del Mar Gutierrez, Ramón W. Román, Paula Suanzes, Juan Ambrosioni, Jordi Casabona, Jose M. Miro, Josep M. Llibre, the PISCIS Study Group
Publikováno v:
Vaccines, Vol 12, Iss 1, p 44 (2023)
People with HIV (PWH) may be more susceptible to SARS-CoV-2 infection and worse clinical outcomes. We investigated the disparity in SARS-CoV-2 vaccination coverage between PWH and those without HIV (PWoH) in Catalonia, Spain, assessing primary and mo
Externí odkaz:
https://doaj.org/article/e511df49e57a45f18c2f7147e03f0236
Autor:
Adrià López-Cano, Neus Ferrer-Miralles, Julieta Sánchez, Jose Vicente Carratalá, Xavier Rodriguez Rodriguez, Imma Ratera, Judith Guasch, Oscar Q. Pich, Paula Bierge, Cristina Garcia-de-la-Maria, Jose M. Miro, Elena Garcia-Fruitós, Anna Arís
Publikováno v:
Pharmaceutics, Vol 15, Iss 4, p 1068 (2023)
Antibiotic resistance has exponentially increased during the last years. It is necessary to develop new antimicrobial drugs to prevent and treat infectious diseases caused by multidrug- or extensively-drug resistant (MDR/XDR)-bacteria. Host Defense P
Externí odkaz:
https://doaj.org/article/70dc93b158004430880f777cb4cd81e7
Autor:
Daniel K. Nomah, Yesika Díaz, Rosa M. Vivanco-Hidalgo, Jordi Casabona, Jose M. Miro, Juliana Reyes-Urueña
Publikováno v:
Enfermedades infecciosas y microbiologia clinica (English ed.). 41:294-297
Autor:
Jose Fernando García-Goez, Juan Diego Vélez, Barbara Lucía Mora, Luis Gabriel Parra-Lara, Jessica Pino-Escobar, Joan Artur Caylà, Jose M. Miro
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 46, Iss 5 (2020)
Externí odkaz:
https://doaj.org/article/01293ce862eb4ddfa354bb8f4dacd3d8
Autor:
Miriam Rosás-Umbert, Marta Ruiz-Riol, Marco A. Fernández, Marta Marszalek, Pep Coll, Christian Manzardo, Samandhy Cedeño, José M. Miró, Bonaventura Clotet, Tomáš Hanke, José Moltó, Beatriz Mothe, Christian Brander, the BCN02 study group, Susana Benet, Anuksa Llano, Javier Martinez-Picado, Sara Morón-López, Roger Paredes, Maria C. Puertas, Roser Escrig, Silvia Gel, Miriam López, Cristina Miranda, Jose Muñoz, Nuria Perez-Alvarez, Jordi Puig, Boris Revollo, Jessica Toro, Ana Maria Barriocanal, Magi Farré, Cristina Perez-Reche, Marta Valle, Juan Ambrosioni, Irene Ruiz, Cristina Rovira, Carmen Ligero, Jose M. Miro, Antonio Carrillo, Michael Meulbroek, Ferran Pujol, Jorge Saz, Nicola Borthwick, Alison Crook, Edmund G. Wee
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Romidepsin (RMD) is a well-characterized histone deacetylase inhibitor approved for the treatment of cutaneous T-cell lymphoma. in vitro and in vivo studies have demonstrated that it is able to induce HIV-1 gene expression in latently infected CD4+ T
Externí odkaz:
https://doaj.org/article/7ff34c69a231482fa4c4bba2e9a493f3
Autor:
Yanink Caro-Vega, Anna Schultze, Anne Marie W. Efsen, Frank A. Post, Alexander Panteleev, Aliaksandr Skrahin, Jose M. Miro, Enrico Girardi, Daria N. Podlekareva, Jens D. Lundgren, Juan Sierra-Madero, Javier Toibaro, Jaime Andrade-Villanueva, Simona Tetradov, Jan Fehr, Joan Caylà, Marcelo H. Losso, Robert F. Miller, Amanda Mocroft, Ole Kirk, Brenda Crabtree-Ramírez
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background Efavirenz-based antiretroviral therapy (ART) regimens are preferred for treatment of adult HIV-positive patients co-infected with tuberculosis (HIV/TB). Few studies have compared outcomes among HIV/TB patients treated with efavire
Externí odkaz:
https://doaj.org/article/a3ab17947e294c4fbb12aa519666bf70
Autor:
Vance G Fowler, David T Durack, Christine Selton-Suty, Eugene Athan, Arnold S Bayer, Anna Lisa Chamis, Anders Dahl, Louis DiBernardo, Emanuele Durante-Mangoni, Xavier Duval, Claudio Fortes, Emil Fosbøl, Margaret M Hannan, Barbara Hasse, Bruno Hoen, Adolf W Karchmer, Carlos A Mestres, Cathy A Petti, María Nazarena Pizzi, Stephen D Preston, Albert Roque, Francois Vandenesch, Jan T M van der Meer, Thomas W van der Vaart, Jose M Miro
Publikováno v:
Clinical Infectious Diseases.
The microbiology, epidemiology, diagnostics, and treatment of infective endocarditis (IE) have changed significantly since the Duke Criteria were published in 1994 and modified in 2000. The International Society for Cardiovascular Infectious Diseases
Autor:
Nagendra N. Mishra, Wessam Abdelhady, Ahmed M. Elsayed, Christian Lapitan, Richard A. Proctor, Michael J. Rybak, Jose M. Miro, Arnold S. Bayer
Publikováno v:
Antimicrobial Agents and Chemotherapy. 67
The Streptococcus mitis -oralis subgroup of the viridans group streptococci (VGS) are the most common cause of infective endocarditis (IE) in many parts of the world. These organisms are frequently resistant in vitro to standard β-lactams (e.g., pen